ArticleCase reports in oncology

Need for Flexible Adjustment of the Treatment Schedule for Aprepitant Administration against Erlotinib-Induced Refractory Pruritus and Skin Rush.

Nobuhiko Seki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.